Saratoga Research & Investment Management Novo Nordisk A S Transaction History
Saratoga Research & Investment Management
- $1.98 Billion
- Q4 2024
A detailed history of Saratoga Research & Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Saratoga Research & Investment Management holds 700,634 shares of NVO stock, worth $55.3 Million. This represents 3.04% of its overall portfolio holdings.
Number of Shares
700,634
Previous 708,519
1.11%
Holding current value
$55.3 Million
Previous $84.4 Million
28.56%
% of portfolio
3.04%
Previous 3.69%
Shares
30 transactions
Others Institutions Holding NVO
# of Institutions
1,884Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.57 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.22 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.03 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$998 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$964 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...